Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
ACS Infectious Diseases|March 19, 2021
Repurposing Infectious Disease Hits as Anti-<i>Cryptosporidium</i> LeadsMatthew A Hulverson, Ryan Choi, Molly C McCloskey, et al.
The Journal of Infectious Diseases|March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyMatthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.
International Journal for Parasitology. Drugs and Drug Resistance|March 5, 2018
Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoitesRoberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, et al.
Plos Neglected Tropical Diseases|July 30, 2025
Anti-Cryptosporidium efficacy of BKI-1708, an inhibitor of Cryptosporidium calcium-dependent protein kinase 1Ryan Choi, Matthew A Hulverson, Deborah A Schaefer, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2023
Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of CryptosporidiosisMatthew A Hulverson, Ryan Choi, Deborah A Schaefer, et al.
Veterinary Parasitology|January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseasesWesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.
International Journal for Parasitology|September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosisMatthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerTakuma Uo, Kayode K Ojo, Cynthia C Sprenger, et al.
Molecular Cancer Therapeutics|March 20, 2024
A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerTakuma Uo, Kayode K Ojo, Cynthia C T Sprenger, et al.
Pageof 22